Javascript must be enabled to continue!
The analysis of X-linked Alport syndrome caused by a novel COL4A5 gene aberrant splicing
View through CrossRef
Abstract
Objective To analyze a novel splicing mutation site in COL4A5 gene in a Chinese X-linked Alport syndrome family, and to show the clinical symptoms in proband and his family, in order to provide a basis for the diagnosis and genetic counseling of the disease. Methods Proband's clinical data were collected from electronic medical records. The underlying genetic causes of AS patients were identified by the whole-exome sequencing (WES). Results The proband had developed hematuria since the age of 3 years old, which was aggravated without obvious inducement on February 2022, accompanied by foamy urine. Renal biopsy revealed mesangial proliferative lesions with ischemic sclerosis. The WES showed a novel nucleotide alteration, NM_000495.5 c.609 + 2T༞G, in COL4A5 gene intron 10 in the proband. This alteration was verified in his mother by the WES. Conclusion A novel COL4A5 gene intron aberrant splicing mutation site was identified. That extended the spectrum of mutations in the COL4A5 gene, and it would be valuable to understand more about the genotype-phenotype correlations.
Research Square Platform LLC
Title: The analysis of X-linked Alport syndrome caused by a novel COL4A5 gene aberrant splicing
Description:
Abstract
Objective To analyze a novel splicing mutation site in COL4A5 gene in a Chinese X-linked Alport syndrome family, and to show the clinical symptoms in proband and his family, in order to provide a basis for the diagnosis and genetic counseling of the disease.
Methods Proband's clinical data were collected from electronic medical records.
The underlying genetic causes of AS patients were identified by the whole-exome sequencing (WES).
Results The proband had developed hematuria since the age of 3 years old, which was aggravated without obvious inducement on February 2022, accompanied by foamy urine.
Renal biopsy revealed mesangial proliferative lesions with ischemic sclerosis.
The WES showed a novel nucleotide alteration, NM_000495.
5 c.
609 + 2T༞G, in COL4A5 gene intron 10 in the proband.
This alteration was verified in his mother by the WES.
Conclusion A novel COL4A5 gene intron aberrant splicing mutation site was identified.
That extended the spectrum of mutations in the COL4A5 gene, and it would be valuable to understand more about the genotype-phenotype correlations.
Related Results
Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
Introduction:Alport syndrome (AS) is an inherited disorder characterized by hematuria, proteinuria, and kidney function impairment, and frequently associated with extrarenal manife...
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract
Alternative mRNA splicing is dysregulated in many cancers including lung adenocarcinoma. These aberrant splicing events can sometimes be explained by mutati...
Genome-wide survey of allele-specific splicing in humans
Genome-wide survey of allele-specific splicing in humans
Abstract
Background
Accurate mRNA splicing depends on multiple regulatory signals encoded in the transcribed RNA sequence. Many examples of mutat...
A Case of Alport Syndrome in an 18-Year-Old Male: Clinical Presentation, Diagnosis, and Multidisciplinary Management
A Case of Alport Syndrome in an 18-Year-Old Male: Clinical Presentation, Diagnosis, and Multidisciplinary Management
Alport syndrome is a rare genetic disorder characterized by progressive kidney failure, sensorineural hearing loss, and eye abnormalities. We present the case of an 18-year-old mal...
Abstract 1423: Integrative analysis predicts lncRNA regulating gene alternative splicing in breast cancer
Abstract 1423: Integrative analysis predicts lncRNA regulating gene alternative splicing in breast cancer
Abstract
Background: Non-coding region occupies 98% of the whole human genome and plays a
regulatory role for protein-coding genes. About 95% of the p...
RBM-5 modulates U2AF large subunit-dependent alternative splicing in
C. elegans
RBM-5 modulates U2AF large subunit-dependent alternative splicing in
C. elegans
Abstract
A key step in pre-mRNA splicing is the recognition of 3’ splicing sites by the U2AF large and small subunits, a process regulated by num...
MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets
MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets
Cancer is a multifaceted disease that involves several molecular mechanisms including changes in gene expression. Two important processes altered in cancer that lead to changes in ...
Regulation of Alternative Splicing in B-Cell ALL By DYRK1A
Regulation of Alternative Splicing in B-Cell ALL By DYRK1A
DYRK1A, located in the Down syndrome critical region of chromosome 21, is a serine and threonine kinase that controls multiple cellular processes including apoptosis, cell cycle, t...

